DOV GORSHEIN, M.D.; EMMANUEL C. BESA, M.D.; FRANK H. GARDNER, M.D.
To the editor: The current concept of remission in acute leukemia is associated with the degree of "cell kill"—longer remissions with greater cell kill. A cure means total cell kill. Weintraub (1) recently proposed that agents effective in therapy for acute leukemia induce differentiation of primitive stem cells.
Treatment with androgens for refractory anemia in a man who had preleukemia resulted in a stable course with a normal hemogram. Cessation of therapy was associated with the development of acute leukemia. It is speculated that androgens trigger cells into a cycle that responds to differentiating factors (erythropoietin), thus keeping the patient
Learn more about subscription options.
Register Now for a free account.
GORSHEIN D, BESA EC, GARDNER FH. Acute Myelomonocytic Leukemia After Cessation of Androgen Therapy. Ann Intern Med. 1973;79:749-750. doi: 10.7326/0003-4819-79-5-749
Download citation file:
Published: Ann Intern Med. 1973;79(5):749-750.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only